EU Science Hub

JRC News

Leukemic monocyte THP-1 cell microarrays for morphology analysis. A) Blue= nuclei B) Green=cyctoscheleton, C) both labelling, D) bright filed
©EU, 2016
Dec 02 2016
JRC scientists, in collaboration with researchers from the University of Lyon (Fr), reviewed the latest advances in multiplex cell microarrays for high-throughput screening allowing for high-throughput analysis.
Battery with a solar panel and wind turbine inside The JRC has supported with scientific evidence the Clean Energy package presented on 30 November 2016.
©Fotolia, Frank Peters
Dec 01 2016
The package pursues three main goals: putting energy efficiency first, cementing the EU's global leadership in renewable energies and providing a fair deal for energy consumers.
A solar panel and a wind turbine Wind, photovoltaics and electric cars rely on materials which have been assessed as being critical.
©Fotolia, davis
Dec 01 2016
A study presented at the 9th SET Plan conference indicates that the EU is vulnerable to supply bottlenecks of several key materials needed in wind, photovoltaic and electric vehicles technologies.
The EU Industrial R&D Investment Scoreboard collects companies' key R&D and economic indicators The EU Industrial R&D Investment Scoreboard collects companies' key R&D and economic indicators
©EU, 2016
Dec 01 2016
The 2016 EU Industrial R&D Investment Scoreboard, published on 1 December by the European Commission, shows that EU companies invested €188.3bn in Research & Development (R&D) in the fiscal year 2015/2016.
Testing Assistive Listening Devices at the JRC Radio Spectrum Laboratory
©Photo by courtesy of Detlef Georg Fuehrer
Dec 01 2016

Assistive Listening Devices (ALD) are devices used in addition to hearing aids (HAs) and cochlear implants to make more sounds accessible to people with hearing impairment. According to the World Health Organization (WHO) over 5% of the world’s population – 360 million people of which 32 million are children – suffer from disabling hearing impairment. Hearing aids are currently used by about 50 million people.

EURL ECVAM Scientific Advisory Committee (ESAC)
©European Commission
Dec 01 2016

The EURL ECVAM's Scientific Advisory Committee (ESAC) Opinions published by the Joint Research Centre's EURL ECVAM (the European Union Reference Laboratory for Alternatives to Animal Testing) are the outcome of the scientific peer review of five validation studies on alternativ

Air missile in space Aeronautics and electronics sectors of defence industry are the most vulnerable to potential disruptions in the supply of materials.
©Fotolia, pgottschalk
Nov 30 2016
A new study contributes to better understanding of the importance of materials supply for the defence value chain, in support of the European Defence Action Plan.
Nov 30 2016
JRC scientists prepared a comprehensive and critical overview of the application of proteomics approaches to determine the authenticity of several food products. Compared to other well established methodologies such as immunoassays or DNA-based analysis, proteomics represents a promising alternative.
Nov 29 2016
JRC scientists investigated whether cancer incidence rates obeyed Benford's law (the law of first digits). Results confirmed that the adherence to Benford's law improves the evaluation of the quality of cancer registry data.
Nov 28 2016
When independent scientific evidence on breast cancer is translated into healthcare quality and policy, the impact on the lives of millions of European women can be absolutely enormous. The first European Breast Cancer Guidelines’ recommendations for screening were launched at the JRC Plenary of the European Commission Initiative on Breast Cancer (ECIBC).